| 摘要 |
The present disclosure relates to aberrations in microRNAs as indicators/biomarkers of head and neck squamous cell carcinomas (HNSCC), method of analysing the role of said indicators/biomarkers in HNSCC, corresponding methods of detection of HNSCC, use and kits thereof. In particular, the present disclosure relates to aberrations in microRNAs in head and neck squamous cell carcinomas (HNSCC), specifically in squamous cell carcinoma of larynx and/or hypopharynx which serve as indicators/biomarkers for such carcinomas and associated methods. |
